Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Immunity and Immunotherapy for HPV-Related Cancers
A. Shamseddine, Bharat Burman, Nancy Y. Lee, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1896-1912
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression
Chenchen Hu, Tianyue Liu, Chenying Han, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 507-521
Open Access | Times Cited: 85
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
Hussein Sabit, Mohamed Abdel-Hakeem, Tahsin Shoala, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1566-1566
Open Access | Times Cited: 55
Single‐cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment
Guangxu Cao, Jiali Yue, Yetian Ruan, et al.
The EMBO Journal (2023) Vol. 42, Iss. 16
Open Access | Times Cited: 28
Advances in immunotherapy for cervical cancer
Juan Francisco Grau-Béjar, Carmen García-Durán, David García-Illescas, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 23
SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis
Yu Wang, Weigang Gu, Weiwei Wen, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 36
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 21
The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence
Silvia Barbosa, Natalia Koerich Laureano, Wahyu Wijaya Hadiwikarta, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 439-439
Open Access | Times Cited: 6
Review of biomarkers for response to immunotherapy in HNSCC microenvironment
Shaoshi Chen, Yifan Yang, Shizhi He, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Immunotherapy in HPV-Related Oropharyngeal Cancers
Logan Roof, Emrullah Yilmaz
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 3, pp. 170-183
Open Access | Times Cited: 14
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
Soledad Iseas, Golubicki Mariano, Louis Gros, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 2, pp. 201-214
Open Access | Times Cited: 5
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Junshang Ge, Yi Meng, Jiayue Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers
Ehsan Zolfi, Farhood Khaleghi mehr, Nikoo Emtiazi, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
Andris M. Evans, Mikhail Salnikov, Steven F. Gameiro, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4825-4825
Open Access | Times Cited: 20
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L. Disis, Sarah F. Adams, Jyoti Bajpai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006624-e006624
Open Access | Times Cited: 12
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal Cancer
Wei Ye, Tingting Xu, Chong Li, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 3, pp. 306-319
Open Access | Times Cited: 11
Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment
Anna Jéssica Duarte Silva, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1354-1354
Open Access | Times Cited: 11
HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers
L. Liu, Yanan Xie, Hong Yang, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 11
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M. Huffman, Harshabad Singh, Lestat R. Ali, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008436-e008436
Open Access | Times Cited: 4
Epidemiologie und Prävention des Oropharynxkarzinoms
Andreas Dietz
HNO (2025)
Closed Access
Leukocyte-specific protein 1 is associated with the stage and tumor immune infiltration of cervical cancer
Dianqin Xu, Xinzhu Zhou, Shaoju Min, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases
Sirui Han, Mengyue Lin, Mengyu Liu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
An innovative glutamine metabolism-related gene signature for predicting prognosis and immune landscape in cervical cancer
Hanji Fang, Limei Ji, Chibo Hong
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Factorial Design-optimized Microfluidic LNP Vaccine Elicits Potent Magnesium-Adjuvating Cancer Immunotherapy
Y. G. Xie, Jiaxin Guo, Jialin Hu, et al.
Materials Today Bio (2025), pp. 101703-101703
Open Access
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
Tynisha S. Rafael, Jossie Rotman, Oscar R. Brouwer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1101-1101
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top